Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.

New England Journal of Medicine

PubMedID: 13707731

GRAHAM JR. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache. N Engl J Med. 1960;2631273-7.
An abstract is not available. Please access the article through the links below.